1,759
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

Evaluation of the hepatoprotective effect of naringenin loaded nanoparticles against acetaminophen overdose toxicity

, , , , , , , , , , & show all
Pages 3256-3269 | Received 01 Sep 2022, Accepted 17 Oct 2022, Published online: 02 Nov 2022

References

  • Ahmad A, Fauzia E, Kumar M, et al. (2019). Gelatin-coated polycaprolactone nanoparticle-mediated naringenin delivery rescue human mesenchymal stem cells from oxygen glucose deprivation-induced inflammatory stress. ACS Biomater Sci Eng 5:683–95.
  • Brodersen R. (1974). Competitive binding of bilirubin and drugs to human serum albumin studied by enzymatic oxidation. J Clin Invest 54:1353–64.
  • Budel RG, daSilva DA, Moreira MP, et al. (2020). Toxicological evaluation of naringin-loaded nanocapsules in vitro and in vivo. Colloids Surf B Biointerfaces 188:110754.
  • Chen M, Li R, Gao Y, et al. (2021). Encapsulation of hydrophobic and low-soluble polyphenols into nanoliposomes by pH-driven method: Naringenin and naringin as model compounds. Foods 10:963.
  • Chen R, Zhai Y-Y, Sun L, et al. (2022). Alantolactone-loaded chitosan/hyaluronic acid nanoparticles suppress psoriasis by deactivating STAT3 pathway and restricting immune cell recruitment. Asian J Pharm Sci 17:268–83.
  • Cordenonsi LM, Bromberger NG, Raffin RP, Scherman EE. (2016). Simultaneous separation and sensitive detection of naringin and naringenin in nanoparticles by chromatographic method indicating stability and photodegradation kinetics. Biomed Chromatogr 30:155–62.
  • da Silva NIO, Salvador EA, Rodrigues Franco I, et al. (2018). Bovine serum albumin nanoparticles induce histopathological changes and inflammatory cell recruitment in the skin of treated mice. Biomed Pharmacother 107:1311–7.
  • Gao Y, Liu W, Wang W, et al. (2018). Polyguluronate sulfate (PGS) attenuates immunological liver injury in vitro and in vivo. Int J Biol Macromol 114:592–8.
  • Ge Y, Chen H, Wang J, et al. (2021). Naringenin prolongs lifespan and delays aging mediated by IIS and MAPK in Caenorhabditis elegans. Food Funct 12:12127–41.
  • Goncalves C, Ramalho MJ, Silva R, et al. (2021). Lipid nanoparticles containing mixtures of antioxidants to improve skin care and cancer prevention. Pharmaceutics 13:2042.
  • Gratieri T, Pinho LAG, Oliveira MA, et al. (2020). Hydroxypropyl-beta-cyclodextrin-complexed naringenin by solvent change precipitation for improving anti-inflammatory effect in vivo. Carbohydr Polym 231:115769.
  • Hua YQ, Zeng Y, Xu J, Xu XL. (2021). Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe(-/-)mice: role of SIRT1. Phytomedicine 81:153412.
  • Huang Y, Hu L, Huang S, et al. (2018). Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Int J Nanomedicine 13:8309–23.
  • Huang ZW, Shi Y, Zhai YY, et al. (2021). Hyaluronic acid coated bilirubin nanoparticles attenuate ischemia reperfusion-induced acute kidney injury. J Control Release 334:275–89.
  • Ji C-l, Dai S, Liu H, et al. (2021). Polyphenols from Securidaca inappendiculata alleviated acute lung injury in rats by inhibiting oxidative stress sensitive pathways. Chin Herb Med 13:381–8.
  • Khan AW, Kotta S, Ansari SH, et al. (2015). Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation. Drug Deliv 22:552–61.
  • Kim JW, Yang D, Jeong H, et al. (2019). Dietary zerumbone, a sesquiterpene, ameliorates hepatotoxin-mediated acute and chronic liver injury in mice. Phytother Res 33:1538–50.
  • Kou L, Huang H, Tang Y, et al. (2022). Opsonized nanoparticles target and regulate macrophage polarization for osteoarthritis therapy: A trapping strategy. J Control Release 347:237–55.
  • Kou L, Jiang X, Tang Y, et al. (2022). Resetting amino acid metabolism of cancer cells by ATB0,+-targeted nanoparticles for enhanced anticancer therapy. Bioact Mater 9:15–28.
  • Kumar RP, Abraham A. (2017). Inhibition of LPS induced pro-inflammatory responses in RAW 264.7 macrophage cells by PVP-coated naringenin nanoparticle via down regulation of NF-kappaB/P38MAPK mediated stress signaling. Pharmacol Rep 69:908–15.
  • Kumar SP, Birundha K, Kaveri K, Devi KT. (2015). Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells. Int J Biol Macromol 78:87–95.
  • Li S, Hong M, Tan HY, et al. (2016). Insights into the role and interdependence of oxidative stress and inflammation in liver diseases. Oxid Med Cell Longev 2016:4234061.
  • Ma H, Yang B, Yu L, et al. (2021). Sevoflurane protects the liver from ischemia-reperfusion injury by regulating Nrf2/HO-1 pathway. Eur J Pharmacol 898:173932.
  • Ma X, Ren X, Guo X, et al. (2019). Multifunctional iron-based Metal-Organic framework as biodegradable nanozyme for microwave enhancing dynamic therapy. Biomaterials 214:119223.
  • Md S, Abdullah S, Awan ZA, Alhakamy NA. (2022). Smart Oral pH-responsive dual layer nano-hydrogel for dissolution enhancement and targeted delivery of naringenin using protein-polysaccharides complexation against colorectal cancer. J Pharm Sci 111:3155–64.
  • Ni D, Wei H, Chen W, et al. (2019). Ceria nanoparticles meet hepatic ischemia-reperfusion injury: The perfect imperfection. Adv Mater 31:e1902956.
  • Niu X, Sang H, Wang J. (2021). Naringenin attenuates experimental autoimmune encephalomyelitis by protecting the intact of blood-brain barrier and controlling inflammatory cell migration. J Nutr Biochem 89:108560.
  • Ouyang B, Poon W, Zhang YN, et al. (2020). The dose threshold for nanoparticle tumour delivery. Nat Mater 19:1362–71.
  • Pan Z, He Q, Zeng J, et al. (2022). Naringenin protects against iron overload-induced osteoarthritis by suppressing oxidative stress. Phytomed 105:154330.
  • Peng J, Li J, Huang J, et al. (2019). p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization. Theranostics 9:8344–61.
  • Shimada Y, Tomita M, Yoshida T, et al. (2015). Inhibition of lipopolysaccharide-induced liver injury in rats treated with a hepatic drug-metabolizing enzyme inducer p,p’-DDT. Exp Toxicol Pathol 67:245–51.
  • Su L, Mao J, Hao M, et al. (2019). Integrated plasma and bile metabolomics based on an UHPLC-Q/TOF-MS and network pharmacology approach to explore the potential mechanism of Schisandra chinensis-protection from acute alcoholic liver injury. Front Pharmacol 10:1543.
  • Tan T, Yang Q, Chen D, et al. (2021). Chondroitin sulfate-mediated albumin corona nanoparticles for the treatment of breast cancer. Asian J Pharm Sci 16:508–18.
  • Tong F, Tang X, Liu D. (2019). Phycocyanin/PEG-b-(PG-g-PEI) attenuated hepatic ischemia/reperfusion-induced pancreatic islet injury and enlarged islet functionality. Int J Nanomedicine 14:339–51.
  • Tsoi KM, MacParland SA, Ma XZ, et al. (2016). Mechanism of hard-nanomaterial clearance by the liver. Nat Mater 15:1212–21.
  • Veiko AG, Lapshina EA, Zavodnik IB. (2021). Comparative analysis of molecular properties and reactions with oxidants for quercetin, catechin, and naringenin. Mol Cell Biochem 476:4287–99.
  • Wang H, Burke LJ, Patel J, et al. (2020). Imaging-based vascular-related biomarkers for early detection of acetaminophen-induced liver injury. Theranostics 10:6715–27.
  • Wang H, He Y, Hou Y, et al. (2020). Novel self-nanomicellizing formulation based on Rebaudioside A: A potential nanoplatform for oral delivery of naringenin. Mater Sci Eng C Mater Biol Appl 112:110926.
  • Wang J, Zhang B. (2018). Bovine serum albumin as a versatile platform for cancer imaging and therapy. Curr Med Chem 25:2938–53.
  • Wang K, Chen Z, Huang L, et al. (2017). Naringenin reduces oxidative stress and improves mitochondrial dysfunction via activation of the Nrf2/ARE signaling pathway in neurons. Int J Mol Med 40:1582–90.
  • Xiao J, Shi J, Cao H, et al. (2007). Analysis of binding interaction between puerarin and bovine serum albumin by multi-spectroscopic method. J Pharm Biomed Anal 45:609–15.
  • Yang F, Hu S, Sheng X, Liu Y. (2020). Naringenin loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in hepatic fibrosis. Biomed Microdevices 22:68.
  • Yang J, Li Q, Zhou XD, et al. (2011). Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells. Mol Cell Biochem 351:29–40.
  • Yao Q, Jiang X, Zhai YY, et al. (2020). Protective effects and mechanisms of bilirubin nanomedicine against acute pancreatitis. J Control Release 322:312–25.
  • Yao Q, Lan QH, Jiang X, et al. (2020). Bioinspired biliverdin/silk fibroin hydrogel for antiglioma photothermal therapy and wound healing. Theranostics 10:11719–36.
  • Yen FL, Wu TH, Lin LT, et al. (2009). Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure. Pharm Res 26:893–902.
  • Zaidun NH, Thent ZC, Latiff AA. (2018). Combating oxidative stress disorders with citrus flavonoid: Naringenin. Life Sci 208:111–22.
  • Zeng W, Jin L, Zhang F, et al. (2018). Naringenin as a potential immunomodulator in therapeutics. Pharmacol Res 135:122–6.
  • Zhang W, Jiang P, Chen Y, et al. (2016). Suppressing the cytotoxicity of CuO nanoparticles by uptake of curcumin/BSA particles. Nanoscale 8:9572–82.
  • Zhong W, Qian K, Xiong J, et al. (2016). Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-kappaB related signaling. Biomed Pharmacother 83:302–13.
  • Zobeiri M, Belwal T, Parvizi F, et al. (2018). Naringenin and its nano-formulations for fatty liver: Cellular modes of action and clinical perspective. Curr Pharm Biotechnol 19:196–205.